Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun;13(3):324-32.
doi: 10.1007/s11940-011-0116-y.

Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders

Affiliations

Anti-NMDA-Receptor Encephalitis and Other Synaptic Autoimmune Disorders

Myrna R Rosenfeld et al. Curr Treat Options Neurol. 2011 Jun.

Abstract

Synaptic autoimmunity may result in a wide variety of symptoms, including catatonia, psychosis, movement disorders, short-term memory deficits, and refractory seizures, so these patients are seen by a wide spectrum of practitioners, who need to be aware of these disorders. In some cases, these disorders occur as a paraneoplastic manifestation of an associated cancer. However, in contrast to the well-known paraneoplastic neurologic disorders of the central nervous system that predominate in older individuals, these novel disorders often affect children and young adults. Additionally, for some syndromes, the presence of a tumor does not necessarily indicate a poor prognosis. Successful treatment of the tumor and immunotherapy often result in recovery, supporting the use of surgery for severely ill patients. In all syndromes, deficits may be reversible despite the duration or severity of symptoms. For example, patients with anti-NMDA-receptor encephalitis who had been in a coma or ventilated for 6-10 months have had full recovery after appropriate treatment.

PubMed Disclaimer

Conflict of interest statement

Disclosure

Conflicts of Interest: M.R. Rosenfeld and J. Dalmau: License fee payments from EUROIMMUN for an NMDA receptor autoantibody test; patent application for NMDAR antibody determination diagnostic test filed in USA and Europe.

References

    1. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36. - PMC - PubMed
    1. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424–34. This article described limbic encephalitis associated with antibodies to AMPA receptors and supported an antibody-mediated pathogenesis by demonstrating that patients’ antibodies alter the synaptic localization and number of AMPA receptors. - PMC - PubMed
    1. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010;9:776–85. This study clarifies that LGI1 is the autoantigen associated with limbic encephalitis previously attributed to voltage-gated potassium channels. - PMC - PubMed
    1. Gable MS, Gavali S, Radner A, et al. Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis. 2009;28:1421–9. - PMC - PubMed
    1. Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol. 2009;66:704–9. - PubMed

LinkOut - more resources